News from relmada therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 18, 2014, 16:35 ET

Relmada Therapeutics Announces Results of Annual Shareholders Meeting

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced the...

Dec 10, 2014, 08:30 ET

Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Dec 03, 2014, 08:00 ET

Relmada Therapeutics Nominated for Buzz of BIO Contest at the 2015 BIO CEO & Investor Conference

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, is pleased to...

Dec 02, 2014, 08:30 ET

Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone

Novel Product Virtually Devoid of Opioid Activity Being Studied in Neuropathic Pain. Relmada Therapeutics, Inc. (OTCQB: RLMD), a...

Nov 24, 2014, 08:30 ET

Relmada Therapeutics To Present At LD MICRO Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Nov 04, 2014, 08:00 ET

Relmada Therapeutics Appoints Michael Becker As Senior Vice President Of Finance And Corporate Development

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Oct 16, 2014, 08:00 ET

Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Oct 02, 2014, 08:15 ET

Relmada Therapeutics Appoints Julie J. Chen As Director of Finance and Operations

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Sep 18, 2014, 07:45 ET

Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development

Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...

Sep 16, 2014, 07:45 ET

Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER

 Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain,...

Sep 10, 2014, 08:00 ET

Relmada Announces The Filing Of Clinical Trial Application In Canada For d-methadone

Relmada Therapeutics, Inc. (OTCBB: RLMD) ("Relmada" or the "Company"), a clinical stage company developing novel therapies for the treatment of...

Sep 09, 2014, 08:15 ET

Relmada Therapeutics, Inc. Provides Its First Corporate Update as a Public Company

 Relmada Therapeutics, Inc., (OTCBB: RLMD), a Nevada corporation (the "Company") developing novel therapies for the treatment of chronic pain,...

Sep 03, 2014, 07:30 ET

Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014

 Relmada Therapeutics, Inc. (OTCQB: RLMD) ("Relmada" or the "Company"), today announced it will be featured as a presenting company at the 16th...

Aug 06, 2014, 10:01 ET

Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker

 Relmada Therapeutics, Inc., (OTCBB: RLMD), a Nevada corporation (the "Company"), a clinical-stage company developing novel therapies for the...

Jul 09, 2014, 07:30 ET

Camp Nine Inc. Announces Corporate Name Change To Relmada Therapeutics Inc.

 Camp Nine, Inc., (OTCBB: CMPE), a Nevada corporation which conducts its operations through Relmada Therapeutics, Inc., a clinical-stage...

Jul 01, 2014, 07:45 ET

Relmada Therapeutics Files Shares Registration Statement

 Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics, Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage...

Jun 19, 2014, 07:30 ET

Relmada Therapeutics to Present at the 2014 BIO International Convention

 Relmada Therapeutics, which currently conducts its operations through Camp Nine, Inc. (the "Company"), (OTCBB: CMPE), a clinical-stage company...

Jun 16, 2014, 07:30 ET

Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction

 Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage...

Dec 11, 2013, 07:00 ET

Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer

 Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Douglas...

Oct 01, 2013, 07:00 ET

Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing

 Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the final...